Apologies for getting this in the wrong thread
The Company believes that demonstrating the financial feasibility of its Coldry technology at increasing scale in the Australian market can only improve its standing in the eyes of its Indian partners and may act to shorten lead times in delivering the integrated Coldry-Matmor project in India.
What do all think this means? Be interested to know. Sounds like the MPA is drifting away imo.
- Forums
- ASX - By Stock
- ECT
- Ann: Shareholder Update
Ann: Shareholder Update, page-4
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.343M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 4003629 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 15249389 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 4003629 | 0.002 |
27 | 35956532 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 15249389 | 23 |
0.004 | 7303519 | 10 |
0.005 | 3296859 | 21 |
0.006 | 3178567 | 7 |
0.007 | 918333 | 2 |
Last trade - 16.12pm 13/11/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online